RANOLAZINE clinical trials

Comparison of the effectiveness of IntraVenous FLECainide plus oral ranolazine versus intravenous flecainide alone in the cardioversion of recent onset atrial fibrillation - a randomized, prospective, multicentre, open-label study, the IV-FLEC study.

This study looks at treating a common heart rhythm problem called atrial fibrillation (AF). Researchers are comparing two treatments: one medicine given into a vein, called flecainide, combined with a tablet called ranolazine, against flecainide alone. The goal is to see which treatment works best and fastest to get the heart back to a normal rhythm.